258 related articles for article (PubMed ID: 29366941)
1. Inorganic nanoparticles: A potential cancer therapy for human welfare.
Pugazhendhi A; Edison TNJI; Karuppusamy I; Kathirvel B
Int J Pharm; 2018 Mar; 539(1-2):104-111. PubMed ID: 29366941
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle delivery systems, general approaches, and their implementation in multiple myeloma.
de la Puente P; Azab AK
Eur J Haematol; 2017 Jun; 98(6):529-541. PubMed ID: 28208215
[TBL] [Abstract][Full Text] [Related]
3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
4. New Strategies in Cancer Nanomedicine.
Tong R; Kohane DS
Annu Rev Pharmacol Toxicol; 2016; 56():41-57. PubMed ID: 26514197
[TBL] [Abstract][Full Text] [Related]
5. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology: An Emerging Therapeutic Option for Breast Cancer.
Hussain Z; Khan JA; Murtaza S
Crit Rev Eukaryot Gene Expr; 2018; 28(2):163-175. PubMed ID: 30055543
[TBL] [Abstract][Full Text] [Related]
7. Targeting of nanoparticles in cancer: drug delivery and diagnostics.
Talekar M; Kendall J; Denny W; Garg S
Anticancer Drugs; 2011 Nov; 22(10):949-62. PubMed ID: 21970851
[TBL] [Abstract][Full Text] [Related]
8. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
Pridgen EM; Langer R; Farokhzad OC
Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
[TBL] [Abstract][Full Text] [Related]
9. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.
Elzoghby AO; Hemasa AL; Freag MS
J Control Release; 2016 Dec; 243():303-322. PubMed ID: 27794493
[TBL] [Abstract][Full Text] [Related]
10. Nanoformulations for Targeted Drug Delivery to Prostate Cancer: An Overview.
Hema S; Thambiraj S; Shankaran DR
J Nanosci Nanotechnol; 2018 Aug; 18(8):5171-5191. PubMed ID: 29458568
[TBL] [Abstract][Full Text] [Related]
11. Copper sulfide nanoparticle-based localized drug delivery system as an effective cancer synergistic treatment and theranostic platform.
Hou L; Shan X; Hao L; Feng Q; Zhang Z
Acta Biomater; 2017 May; 54():307-320. PubMed ID: 28274767
[TBL] [Abstract][Full Text] [Related]
12. [Progress in the study of drug delivery system based on nanoparticles to overcome multi-drug resistance].
Chen JN; Shen Q; Li SS
Yao Xue Xue Bao; 2009 Apr; 44(4):333-7. PubMed ID: 19545047
[TBL] [Abstract][Full Text] [Related]
13. Applications and strategies in nanodiagnosis and nanotherapy in lung cancer.
Woodman C; Vundu G; George A; Wilson CM
Semin Cancer Biol; 2021 Feb; 69():349-364. PubMed ID: 32088362
[TBL] [Abstract][Full Text] [Related]
14. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
15. Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and Imaging.
Glasgow MD; Chougule MB
J Biomed Nanotechnol; 2015 Nov; 11(11):1859-98. PubMed ID: 26554150
[TBL] [Abstract][Full Text] [Related]
16. Nanomedicine for Treatment of Lung Cancer.
Hussain S
Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnology for the delivery of phytochemicals in cancer therapy.
Xie J; Yang Z; Zhou C; Zhu J; Lee RJ; Teng L
Biotechnol Adv; 2016; 34(4):343-353. PubMed ID: 27071534
[TBL] [Abstract][Full Text] [Related]
18. Cancer chemoprevention by polyphenols and their potential application as nanomedicine.
Tabrez S; Priyadarshini M; Urooj M; Shakil S; Ashraf GM; Khan MS; Kamal MA; Alam Q; Jabir NR; Abuzenadah AM; Chaudhary AG; Damanhouri GA
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2013; 31(1):67-98. PubMed ID: 23534395
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles and targeted drug delivery in cancer therapy.
Bahrami B; Hojjat-Farsangi M; Mohammadi H; Anvari E; Ghalamfarsa G; Yousefi M; Jadidi-Niaragh F
Immunol Lett; 2017 Oct; 190():64-83. PubMed ID: 28760499
[TBL] [Abstract][Full Text] [Related]
20. Nanoparticle therapeutics for prostate cancer treatment.
Sanna V; Sechi M
Nanomedicine; 2012 Sep; 8 Suppl 1():S31-6. PubMed ID: 22640911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
